Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Starling Oncology, Inc.Security delisted | Other | $15.1K | SEC | ||
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | Buy | $9.4K | conv 67ClusterFirst in 12mo | SEC | |
Starling Oncology, Inc.Security delisted | BuyD (derivative) | $588.6 | ClusterFirst in 12mo | SEC | |
Starling Oncology, Inc.Security delisted | Other | $180.8 | SEC | ||
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |